(Q51151839)

31 March 2018

title

Dynamic gadoxetate-enhanced MRI for the assessment of total and segmental liver function and volume in primary sclerosing cholangitis. (English)

1 reference

31 March 2018

primary sclerosing cholangitis

main subject

ascending cholangitis

0 references

1 reference

8

1 reference

31 March 2018

Henrik Nilsson

object named as

Henrik Nilsson

1

0 references

author name string

Lennart Blomqvist

2

1 reference

31 March 2018

Lena Douglas

3

1 reference

31 March 2018

Anders Nordell

4

1 reference

31 March 2018

Hans Jacobsson

5

1 reference

31 March 2018

Karin Hagen

6

1 reference

31 March 2018

Annika Bergquist

7

1 reference

31 March 2018

publication date

10 October 2013

1 reference

31 March 2018

Journal of Magnetic Resonance Imaging

published in

1 reference

31 March 2018

volume

39

1 reference

31 March 2018

issue

4

1 reference

31 March 2018

page(s)

879-886

1 reference

31 March 2018

Liver transplantation for primary sclerosing cholangitis: timing, outcome, impact of inflammatory bowel disease and recurrence of disease

cites work

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24250

Transporters involved in the hepatic uptake of (99m)Tc-mebrofenin and indocyanine green

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24250

Expression of OATP1B3 determines uptake of Gd-EOB-DTPA in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24250

Hepatocellular carcinoma: signal intensity at gadoxetic acid-enhanced MR Imaging--correlation with molecular transporters and histopathologic features.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24250

Hepatic uptake of the magnetic resonance imaging contrast agent Gd-EOB-DTPA: role of human organic anion transporters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24250

Assessment of liver function in primary biliary cirrhosis using Gd-EOB-DTPA-enhanced liver MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24250

Different concentrations of various radiopharmaceuticals in the two main liver lobes: a preliminary study in clinical patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24250

Quantitative evaluation of liver function with MRI Using Gd-EOB-DTPA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24250

Quantitative evaluation of liver function with use of gadoxetate disodium-enhanced MR imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24250

Liver parenchymal enhancement of hepatocyte-phase images in Gd-EOB-DTPA-enhanced MR imaging: which biological markers of the liver function affect the enhancement?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24250

EASL Clinical Practice Guidelines: management of cholestatic liver diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24250

Method for quantitation of dynamic MRI contrast agent uptake in colorectal liver metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24250

Assessment of hepatic extraction fraction and input relative blood flow using dynamic hepatocyte-specific contrast-enhanced MRI

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24250

21 January 2018

Identifiers

DOI

10.1002/JMRI.24250

1 reference

31 March 2018

1 reference

31 March 2018